VIR CIK: 1706431

Vir Biotechnology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.56
FY22:
2.52
FY23:
1.59
FY24:
1.04
FY25:
0.51
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.39
FY22:
0.28
FY23:
0.33
FY24:
0.36
FY25:
0.49
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.95
FY22:
2.80
FY23:
1.92
FY24:
1.40
FY25:
1.00

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.34
FY22:
0.51
FY23:
0.18
FY24:
0.12
FY25:
0.09
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.18
FY22:
0.21
FY23:
0.15
FY24:
0.13
FY25:
0.14
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.43
FY22:
2.08
FY23:
1.59
FY24:
1.15
FY25:
0.77
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.95
FY22:
2.80
FY23:
1.92
FY24:
1.40
FY25:
1.00

All amounts in billions USD Data source:SEC EDGAR